propentofylline has been researched along with minocycline in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alkaitis, MS; Deleo, JA; Horvath, RJ; Nutile-McMenemy, N | 1 |
Asaki, T; Fujita, M; Hasegawa, M; Omachi, S; Rokushima, M; Sakaguchi, G; Shinohara, S; Tamano, R; Yogo, E; Yoneda, S | 1 |
Alves-Filho, JC; Cecilio, NT; Cunha, FQ; Cunha, TM; Davoli-Ferreira, M; Ferreira, DW; Fonseca, MM; Guimaraes, RM; Kusuda, R; Lopes, AH; Nachbur, U; Santa-CecĂlia, FV; Souza, GR; Teixeira, MM; Zamboni, DS | 1 |
3 other study(ies) available for propentofylline and minocycline
Article | Year |
---|---|
Differential migration, LPS-induced cytokine, chemokine, and NO expression in immortalized BV-2 and HAPI cell lines and primary microglial cultures.
Topics: Animals; Animals, Newborn; Calcium-Binding Proteins; Cell Movement; Cells, Cultured; Cerebral Cortex; Cytokines; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Extracellular Signal-Regulated MAP Kinases; Lipopolysaccharides; Mice; Microfilament Proteins; Microglia; Minocycline; Neuroprotective Agents; Nitric Oxide; Rats; Time Factors; Xanthines | 2008 |
Ibudilast produces anti-allodynic effects at the persistent phase of peripheral or central neuropathic pain in rats: Different inhibitory mechanism on spinal microglia from minocycline and propentofylline.
Topics: Animals; Encephalomyelitis, Autoimmune, Experimental; Female; Humans; Hyperalgesia; Injections, Spinal; Male; Microglia; Minocycline; Neuralgia; Neuroprotective Agents; p38 Mitogen-Activated Protein Kinases; Pain Measurement; Peripheral Nerve Injuries; Phosphodiesterase Inhibitors; Phosphorylation; Pyridines; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Sciatic Nerve; Spinal Cord; Xanthines | 2018 |
The NOD2 signaling in peripheral macrophages contributes to neuropathic pain development.
Topics: Animals; Bone Marrow Transplantation; Carrageenan; Disease Models, Animal; Inflammation; Interleukin 1 Receptor Antagonist Protein; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Minocycline; Neuralgia; Neuroprotective Agents; Nod2 Signaling Adaptor Protein; Receptor-Interacting Protein Serine-Threonine Kinase 2; Receptor-Interacting Protein Serine-Threonine Kinases; Receptors, Tumor Necrosis Factor, Type I; RNA, Small Interfering; Signal Transduction; Toll-Like Receptor 4; Xanthines | 2019 |